Investor profile
Delaware Crossing Investor Group
Angel syndicate
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Delaware Crossing Investor Group (DCIG) is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and other growth-oriented companies. Members back entrepreneurs and their companies by contributing investment capital and important domain expertise in a wide array of industries. DCIG invests primarily in high growth industries, such as information technology and life sciences. The group focuses on reaching entrepreneurial and investor communities on both sides of the Delaware River and throughout the Mid-Atlantic Region. During the screening and investment process, many factors are considered such as strength of the management team, growth prospects, competitive dynamics within the market addressed, and the business model. Investments are typically in Series A Preferred Stock, although convertible debt structures are also considered.
Team
Michael Cirafesi
Partner
Antonio Tedesco
Partner
Mark Mitchell
Managing Director
Jeff Snellenburg
Executive Director, Mid-Atlantic Angel Group Funds
Michael J. Kelly
Managing Director, Yellow Thread Ventures
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Vytala | Seed | — | 2024-09 |
| Novira Therapeutics | Early Stage VC | $25m | — |
| Edge Therapeutics | Early Stage VC | — | — |
| Immunome | Early Stage VC | — | — |
| Annovis Bio | Early Stage VC | — | — |
| Medcura | Early Stage VC | $3m | — |
| Life.io | Seed | $2m | — |
| Stabiliz Orthopaedics | Seed | $1m | — |
| Compliance Assurance Corporation | Later Stage VC | $1m | — |
| NanoPack | Later Stage VC | $1m | — |
Fit check
Is Delaware Crossing Investor Group a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit